mirnomes

  1. Sly Saint

    Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and ME/CFS:Striking Back on Treatments 2019 Oltra et al

    Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments Eloy Almenar-Pérez 1, Teresa Sánchez-Fito 1, Tamara Ovejero 2, Lubov Nathanson 3,4 and Elisa Oltra 2,5,* 1 Escuela de...
Back
Top Bottom